Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4554151000168115 | Trientine (DRLA) (trientine dihydrochloride 250 mg) capsule, 100 capsules, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4554161000168118 | Trientine (DRLA) 250 mg capsule, 100, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trientine (DRLA) 250 mg capsule, 100, bottle | Is a | Trientine (DRLA) 250 mg capsule, 100 | true | Inferred relationship | Some | ||
| Trientine (DRLA) 250 mg capsule, 100, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Trientine (DRLA) 250 mg capsule, 100, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Trientine (DRLA) 250 mg capsule, 100, bottle | has TP | Trientine (DRLA) | true | Inferred relationship | Some | ||
| Trientine (DRLA) 250 mg capsule, 100, bottle | has TPUU | Trientine (DRLA) 250 mg capsule | true | Inferred relationship | Some | 2122321481 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Black Triangle Scheme reference set
Containered trade product pack reference set
FHIR